Banyanhill iconBanyanhillSep 25, 2026 ~6 min source read

How Jaguar Health’s +2,261% Intraday Spike Happened — Reverse Splits, Dilution, and a Tiny Float

A volatile run in Jaguar Health (JAGX) came from structural mechanics — repeated reverse splits and dilution — plus a thin float and positive FDA fee news that triggered a classic short squeeze.

The Secret Behind +2,261% Day Spike

Share this story

Send the public story page.

Useful takeaways from this story.

A 1-for-15 reverse split on Sept. 17 cut the public float to roughly 345,000 shares, making the stock highly sensitive to any pickup in buying.

News that the FDA waived fees for two diarrhea-related drug applications triggered buying in a tiny float, chat-room attention, halts, and an aggressive short squeeze that pushed the stock up more than +2,261% intraday.

# What happened On Sept. 22, Jaguar Health Inc. (JAGX) opened near $2.80 and briefly traded up to $65.75 in after-hours, an intraday move that reached +2,261%. The spike followed an FDA-related announcement and unfolded against a background of extreme share-count engineering: multiple reverse splits and repeated offerings that left the company with a tiny float.

# Why the structure matters Since 2018 Jaguar Health completed eight reverse stock splits. A recent 1-for-15 reverse split on Sept. 17 reduced the float to roughly 345,000 shares. The article traces that pattern into what it calls a "64 Trillion Share Dilution Doom Loop": repeated dilution through offerings followed by reverse splits to meet exchange price rules.

The mechanics the writer describes:

  • The company issues shares to raise cash, diluting existing holders and depressing the share price.
  • If the price falls under exchange minimums for extended periods, the company faces delisting risk and implements reverse splits to lift the per-share price.

The practical result: with a very small public float, even modest buying interest or short-covering can produce outsized percentage moves.

# The trigger Jaguar announced the FDA waived fees for one human-related and one dog-related diarrhea medication. That is positive news for the company's regulatory path. In the context of a ~345K-share float, the announcement was enough to ignite buying, draw retail chat-room attention, and attract short sellers — the conditions for a rapid squeeze.

# How the squeeze played out During regular trading the stock experienced many halts and large intraday gaps. The combination of tiny float, news-driven buying, and an active short interest created a highly volatile environment. The author reports the stock topped +2,261% at one point and notes short sellers were "absolutely crushed." By the time the piece was written, the stock had already fallen back into the $16 range.

# The author's trade and tactical choice

# Takeaway for traders This event illustrates how corporate actions (reverse splits and dilution) can create microstructure vulnerabilities. A tiny float can magnify news into extreme percentage moves and make the stock dangerous and unpredictable. The same structural setup that permits a massive one-day gain also indicates high risk for rapid reversals once buying subsides or profit-taking begins.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app